The Wall Street Journal on Friday, December 30, published a portion of an op-ed by our CEO and Executive Director, Sharen I. Duke, about the need to save the 340B Pharmacy benefit that remains in jeopardy, slated to end this Spring, unless Governor Hochul intervenes. “Thirty years ago, the federal government created the 340B program to ensure that people in under-resourced communities have access to quality treatment and lifesaving medications,” writes Sharen.
“The 340B program enables safety-net providers to stretch scarce federal resources by reinvesting savings into patient care—all at zero additional cost to taxpayers.”